Conclusions The use of eGFR or CrCl to determine metformin eligibility instead of sCr can expand ... (sCr) ≥1.4 mg/dL for women and ≥1.5 mg/dL for men, or abnormal creatinine clearance ...

Metformin is considered to be the first-choice agent and the “gold standard” for most people with type 2 diabetes. Skip to content. ... or abnormal creatinine clearance, ...

Metformin is a common treatment for diabetes. But it can cause digestive problems and other side effects. Learn more about the uses and side effects here.

Metformin is used to help treat type 2 diabetes. Mild side effects, such as nausea, vomiting, and diarrhea, are common and go away with time. But, some serious side effects may require medical ...

Third, while various GFR- and CrCl-estimating equations identify different populations of individuals eligible/ineligible for metformin and all expand the population of people with diabetes for ...